FdaApplication

NDA 017661

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date1992-08-21

Products (3)

ProductActive ingredientStrengthDosage form
TAVISTCLEMASTINE FUMARATE2.68MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
TAVIST-1CLEMASTINE FUMARATE1.34MGTABLET;ORAL
TAVIST-1CLEMASTINE FUMARATE1.34MGTABLET;ORAL

3 products